Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer
- 1 May 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (8) , 1089-1096
- https://doi.org/10.1016/s0959-8049(03)00069-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902Journal of Clinical Oncology, 2001
- Primary Chemotherapy for Operable Breast Cancer: Incidence and Prognostic Significance of Ipsilateral Breast Tumor Recurrence After Breast-Conserving SurgeryJournal of Clinical Oncology, 2001
- Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issuesJournal of the American College of Surgeons, 2000
- Short and long‐term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trialBreast Cancer Research and Treatment, 1999
- Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-upAnnals of Oncology, 1999
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Primary chemotherapy for early and advanced breast cancerCancer Letters, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancerAnnals of Oncology, 1994